Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ciena | CIEN | Nov 19, 2024 | 67.10 | +0.78 |
Cigna | CI | Nov 19, 2024 | 322.50 | +0.02 |
CIMG | IMG | Nov 19, 2024 | 0.54 | 0.00 |
Cimpress | CMPR | Nov 19, 2024 | 77.03 | +0.25 |
Cincinnati Financial | CINF | Nov 19, 2024 | 150.58 | -1.02 |
Cinemark | CNK | Nov 19, 2024 | 33.45 | +4.56 |
Cineverse A | CNVS | Nov 19, 2024 | 3.84 | +8.47 |
Cingulate | CING | Nov 19, 2024 | 4.10 | +1.99 |
Cintas | CTAS | Nov 19, 2024 | 217.97 | +0.82 |
Cion Investment | CION | Nov 19, 2024 | 11.48 | -0.17 |
Cipher Mining | CIFR | Nov 19, 2024 | 6.68 | +2.30 |
Cirrus Logic | CRUS | Nov 19, 2024 | 100.58 | -0.48 |
Cisco Systems | CSCO | Nov 19, 2024 | 57.01 | -0.52 |
CISO Global | CISO | Nov 19, 2024 | 1.04 | -16.13 |
Citi Trends | CTRN | Nov 19, 2024 | 17.79 | +8.97 |
Citigroup | C | Nov 19, 2024 | 68.60 | -0.58 |
Citigroup Capital XIII Trust | C-N | Nov 19, 2024 | 30.13 | -0.26 |
Citius Oncology | CTOR | Nov 19, 2024 | 0.98 | +1.43 |
Citius Pharmaceuticals | CTXR | Nov 19, 2024 | 0.19 | -14.45 |
Citizens & Northern | CZNC | Nov 19, 2024 | 20.02 | -0.45 |
Citizens A | CIA | Nov 19, 2024 | 4.58 | -1.72 |
Citizens Community Bancorp | CZWI | Nov 19, 2024 | 15.10 | +1.82 |
Citizens Financial Group | CFG | Nov 19, 2024 | 46.05 | -1.12 |
Citizens Financial Group D Pref | CFG-D | Nov 19, 2024 | 24.99 | 0.00 |
Citizens Financial Group E Pref | CFG-E | Nov 19, 2024 | 20.72 | -1.38 |
Citizens Financial Group Pref H | CFG-H | Nov 19, 2024 | 26.99 | -0.18 |
Citizens Financial Services | CZFS | Nov 19, 2024 | 70.00 | -0.21 |
City Holding | CHCO | Nov 19, 2024 | 128.65 | -0.12 |
City Office REIT | CIO | Nov 19, 2024 | 4.92 | +1.86 |
City Office REIT A Pref | CIO-A | Nov 19, 2024 | 17.94 | +0.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.